Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy.

Gautschi O, Stadelmann C, Aebersold-Keller F, König K, Büttner R, Heukamp LC, Betticher D, Baumann C, Buser K, Calderoni A, Casty A, DʼAddario G, Irlé C, Mamot C, Morant R, Trojan A, Pellicioli E, Jehle-Schwertfeger S, Aebi S, Diebold J.

Oncol Res Treat. 2015;38(11):560-9. doi: 10.1159/000441367. Epub 2015 Oct 21.

PMID:
26599269
2.

Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient.

Pfrommer S, Weber A, Dutkowski P, Schäfer NG, Müllhaupt B, Bourquin JP, Breitenstein S, Pestalozzi BC, Stenner F, Renner C, D'Addario G, Graf HJ, Knuth A, Clavien PA, Samaras P.

Case Rep Oncol. 2013 Sep 28;6(3):497-503. doi: 10.1159/000355320. eCollection 2013.

3.

What do European community oncologists expect from the European Society for Medical Oncology? Results from a survey among community oncologists in Germany, Greece, Hungary, Italy, Luxembourg, Romania, and Spain.

Eckert R, Curca R, D'Addario G, Lanzetta G, Martorell PM, Mauri D, Rauh S, Schmitz S, Tamas K, Karamouzis MV.

Ann Oncol. 2013 May;24(5):1419-20. doi: 10.1093/annonc/mdt101. Epub 2013 Mar 15. No abstract available.

4.

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).

Pesce GA, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar CB, Fischer N, Anchisi S, Peters S, Cathomas R, Bernhard J, Kotrubczik NM, D'Addario G, Pilop C, Weber DC, Bodis S, Pless M, Mayer M, Stupp R.

Eur J Cancer. 2012 Feb;48(3):377-84. doi: 10.1016/j.ejca.2011.10.016. Epub 2011 Nov 15.

PMID:
22093943
5.

Extended replacement of a calcified ascending aorta in adulthood sporadic, diffuse type, supravalvular aortic stenosis.

Borghetti V, D'Addario G, Bravi I, Pardinia A.

Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):234-6. doi: 10.1510/icvts.2010.261719. Epub 2011 May 4.

6.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D'Addario G, Früh M, Reck M, Baumann P, Klepetko W, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v116-9. doi: 10.1093/annonc/mdq189. No abstract available.

7.

Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009.

Stiefel F, Barth J, Bensing J, Fallowfield L, Jost L, Razavi D, Kiss A; participants.

Ann Oncol. 2010 Feb;21(2):204-7. doi: 10.1093/annonc/mdp564. Epub 2009 Dec 21. Review.

8.

Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report.

Spirig C, Omlin A, D'Addario G, Loske KD, Esenwein P, Geismar JH, Ruhstaller T.

J Med Case Rep. 2009 Nov 2;3:93. doi: 10.1186/1752-1947-3-93.

9.

Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival.

Cerny D, Cerny T, Ess S, D'Addario G, Früh M.

Onkologie. 2009 Oct;32(10):569-73. doi: 10.1159/000232581. Epub 2009 Sep 14.

PMID:
19816073
10.

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

D'Addario G, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2009 May;20 Suppl 4:68-70. doi: 10.1093/annonc/mdp132. Review. No abstract available.

11.

Aortic valve re-implantation technique with Gelweave Valsalva prosthesis: safety, reproducibility and pitfalls of a geometric reconstruction.

Borghetti V, Dionisi D, Principi M, Buratta MM, Fiaschini P, Fioriello F, D'addario G, Patella M, Camilli G, Bovelli D, Pardini A.

J Cardiovasc Med (Hagerstown). 2009 Nov;10(11):834-41. doi: 10.2459/JCM.0b013e32832e0acc.

PMID:
19521255
12.

Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung.

Omlin A, D'Addario G, Gillessen S, Cerny T, von Hessling A, Früh M.

Lung Cancer. 2009 Sep;65(3):383-4. doi: 10.1016/j.lungcan.2009.03.019. Epub 2009 Apr 17.

PMID:
19375814
13.

Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.

Bottomley A, Debruyne C, Felip E, Millward M, Thiberville L, D'Addario G, Rome L, Zatloukal P, Coens C, Giaccone G.

Eur J Cancer. 2008 Oct;44(15):2178-84. doi: 10.1016/j.ejca.2008.06.036.

PMID:
18676140
14.

Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer.

Früh M, Gillessen S, Cerny T, Demmer R, D'Addario G.

Lung Cancer. 2008 Dec;62(3):344-50. doi: 10.1016/j.lungcan.2008.03.028. Epub 2008 May 15.

PMID:
18485522
15.

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

D'Addario G, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii39-40. doi: 10.1093/annonc/mdn081. No abstract available.

16.

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.

D'Addario G, Rauch D, Stupp R, Pless M, Stahel R, Mach N, Jost L, Widmer L, Tapia C, Bihl M, Mayer M, Ribi K, Lerch S, Bubendorf L, Betticher DC.

Ann Oncol. 2008 Apr;19(4):739-45. Epub 2007 Dec 19.

17.

[Mitral regurgitation and left ventricular dysfunction: pathophysiology and surgical therapy].

Borghetti V, Nardi S, Bovelli D, Fioriello F, D'Addario G, Fiaschini P, Pardini A.

G Ital Cardiol (Rome). 2007 Aug;8(8):498-507. Review. Italian.

PMID:
17695701
18.

Importance of surgical timing on postoperative outcome in patients with native valve acute endocarditis.

Borghetti V, Bovelli D, D'Addario G, Fiaschini P, Fioriello F, Nardi S, Cappanera S, Pardini A.

J Cardiovasc Med (Hagerstown). 2006 Nov;7(11):793-9.

PMID:
17060804
19.

Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).

Giaccone G, Debruyne C, Felip E, Chapman PB, Grant SC, Millward M, Thiberville L, D'addario G, Coens C, Rome LS, Zatloukal P, Masso O, Legrand C.

J Clin Oncol. 2005 Oct 1;23(28):6854-64.

20.

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.

D'Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA.

J Clin Oncol. 2005 May 1;23(13):2926-36. Epub 2005 Feb 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk